Apple, Twitter and Twilio Rise Premarket By Investing.com

© Reuters.

By Peter Nurse 

Investing.com — Stocks in focus in premarket trade on Monday, October 12th. Please refresh for updates.

  • Regeneron (NASDAQ:) stock fell 0.2% after the company’s CEO said Sunday that its Covid-19 treatment still needs more testing before its efficacy is known, this despite President Trump calling it a ‘cure’. 

  • DraftKings (NASDAQ:) stock rose 3.2% after Credit Suisse (SIX:) started its coverage of the sports betting operator with an outperform rating, citing an acceleration in sports betting/gaming legalization in the U.S. following the pandemic.

  • Apple (NASDAQ:) stock rose 3.2% ahead of the tech giant’s launch event on Tuesday, which is expected to showcase the new 5G iPhone 12.

  • Travelers (NYSE:) stock fell 1.6% after JPMorgan (NYSE:) downgraded its rating to underweight from neutral, citing concerns over poor return on equity, lackluster business trends and potential earnings risk.

  • Twilio (NYSE:) stock rose 5.3% after reports that it intends to buy customer data startup Segment, with a price tag of $3.2 billion.

  • Twitter (NYSE:) stock rose 4.8% after Deutsche Bank (DE:) upgraded its investment recommendation to “buy”. With a $56 price target, the German bank points to a potential upside of 22%.

  • Snowflake (NYSE:) stock rose 4.4% after the software company started to receive a series of investment recommendations after its IPO, including a “buy” from Goldman Sachs (NYSE:) and an “outperform” from Oppenheimer.

  • Astrazeneca (LON:) ADR stock rose 1% after the U.S. government awarded $486 million to the pharma giant to develop and secure supplies of up to 100,000 doses of its Covid-19 antibody treatment.

  • Levi Strauss (NYSE:) stock rose 3.6% after Morgan Stanley (NYSE:) upgraded the jeans and apparel maker to “overweight” from “equal-weight”, citing the management’s quick response to a difficult retail environment as well as strong revenue growth.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*